A proposed trumping scheme for other specified feeding or eating disorder: Comment on Walsh et al., 2023.

ARFID OSFED atypical anorexia nervosa binge-eating disorder (of low frequency and/or limited duration) bulimia nervosa (of low frequency and/or limited duration) feeding and eating disorders night eating syndrome other specified eating or feeding disorder purging disorder subthreshold avoidant/restrictive food intake disorder

Journal

The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226

Informations de publication

Date de publication:
04 2023
Historique:
revised: 18 01 2023
received: 02 01 2023
accepted: 18 01 2023
medline: 12 4 2023
pubmed: 4 2 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

The recent systematic review by Walsh, Hagan, & Lockwood (Int J Eat Disord, 2022) highlights the importance of further distinguishing atypical anorexia nervosa (atypical AN) from other feeding and eating disorders. The lack of a trumping scheme within other specified feeding or eating disorder (OSFED) hinders intervention selection in the clinical context and reduces reliability of diagnostic classification in research samples. Thus, we propose a trumping scheme within OSFED that mirrors the existing diagnostic algorithm in the main DSM-5-TR feeding and eating disorders section. According to this scheme, a diagnosis of atypical AN would override all other OSFED subcategories. Subthreshold bulimia nervosa (BN) would trump subthreshold binge-eating disorder (BED) and purging disorder; purging disorder would trump subthreshold BED and night eating syndrome; night eating syndrome would trump subthreshold BED; and subthreshold BED would trump subthreshold avoidant/restrictive food intake disorder (ARFID)-a novel presentation that we propose adding under the OSFED umbrella to parallel the existing subthreshold classifications for the main feeding and eating disorders. We hope this proposed OSFED trumping scheme will improve intervention selection and diagnostic reliability in clinical and research contexts, and serve as a catalyst for future research on these newly recognized-but common and impairing-feeding and eating disorder presentations.

Identifiants

pubmed: 36737255
doi: 10.1002/eat.23906
doi:

Types de publication

Case Reports Journal Article Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

835-837

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Academy for Eating Disorders Psychological Care Guidelines Task Force. (2020). A guide to selecting evidence-based psychological therapies for eating disorders (1st ed.). Academy for Eating Disorders.
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed.) text rev. Arlington, VA: American Psychiatric Association.
Breithaupt, L., Kahn, D. L., Slattery, M., Plessow, F., Mancuso, C., Izquierdo, A., Dreier, M. J., Becker, K., Franko, D. L., Thomas, J. J., Holsen, L., Lawson, E. A., Misra, M., & Eddy, K. T. (2022). Eighteen-month course and outcome of adolescent restrictive eating disorders: Persistence, crossover, and recovery. Journal of Clinical Child and Adolescent Psychology, 51(5), 715-725.
Bryant-Waugh, R., Micali, N., Cooke, L., Lawson, E. A., Eddy, K. T., & Thomas, J. J. (2019). Development of the pica, ARFID, and rumination disorder interview, a multi-informant, semi-structured interview of feeding disorders across the lifespan: A pilot study for ages 10-22. International Journal of Eating Disorders, 52(4), 378-387.
Walsh, T. B., Hagan, K. E., & Lockwood, C. (2022). A systematic review comparing atypical anorexia nervosa and anorexia nervosa. International Journal of Eating Disorders, 56(4), 798-820.

Auteurs

Jennifer J Thomas (JJ)

Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

Julia E Gydus (JE)

Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH